Robert Roe explores the use of AI technology in healthcare and medicinal research
Robert Roe explores efforts to diversify the HPC processor market
Robert Roe looks at the role of integrators to deliver and support HPC systems
Robert Roe reports back from SC17 conference on high performance computing
Robert Roe reports from the SC17 conference keynote, detailing progress on the Square kilometre Array project
Robert Roe reports on the potentially far-reaching benefits of exascale computing for European research
Robert Roe finds that as cloud computing matures, it is attracting new users who are choosing to adopt it to supplement existing computing resources
Gemma Church explores applications at the forefront of HPC research
Adrian Giordani explores the methods used to accurately measure the performance of supercomputers
Robert Roe looks at advances in AI computing technology
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
